These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9356783)
1. The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension. Martínez M; Vayá A; Labios M; Gabriel F; Guiral V; Aznar J Clin Hemorheol Microcirc; 1997; 17(3):193-8. PubMed ID: 9356783 [TBL] [Abstract][Full Text] [Related]
2. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension]. Korbut RA; Adamek-Guzik T Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252 [TBL] [Abstract][Full Text] [Related]
3. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension. Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040 [TBL] [Abstract][Full Text] [Related]
4. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment. Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745 [TBL] [Abstract][Full Text] [Related]
5. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension]. Román O; Cuevas G; Bunout D Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766 [TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
8. [Changes in blood rheological properties in patients with hypertension]. Shabanov VA; Terekhina EV; Kostrov VA Ter Arkh; 2001; 73(10):70-3. PubMed ID: 11763523 [TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity. Muravyov AV; Meiselman HJ; Yakusevich VV; Zamishlayev AV Clin Hemorheol Microcirc; 2002; 26(2):125-35. PubMed ID: 12082261 [TBL] [Abstract][Full Text] [Related]
10. Lack of effects of calcium antagonists on red blood cell deformability in hypertension. Lin MS; Huang CS; Leen DY Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):585-7. PubMed ID: 3209275 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive persistence and drug class. Marentette MA; Gerth WC; Billings DK; Zarnke KB Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422 [TBL] [Abstract][Full Text] [Related]
12. [Beneficial effects of statins and angiotensin converting enzyme inhibitors on aggregability of red blood cells in hypertensive patients]. Korbut RA; Guzik B; Adamek-Guzik T; Korbut R Folia Med Cracov; 2006; 47(1-4):37-49. PubMed ID: 18038611 [TBL] [Abstract][Full Text] [Related]
13. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy. Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177 [TBL] [Abstract][Full Text] [Related]
14. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
15. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [TBL] [Abstract][Full Text] [Related]
16. [Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients]. Markova LI; Kuznetsova IV; Radzevich AE Ter Arkh; 2004; 76(11):41-3. PubMed ID: 15658536 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
19. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
20. [Study on the compliance of antihypertensive drugs in patients with hypertension]. Guo H; He H; Jiang J Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):418-20. PubMed ID: 11851054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]